AVXL vs RVTY · $247.4M cap vs P/E 42, rev $1.44B
Anavex Life Sciences Corp (AVXL) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Anavex Life Sciences Corp (AVXL) is a biotechnology company listed on NASDAQ.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
AVXL does not have a complete income-statement cache yet.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
AVXL currently screens at market cap $247.4M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the AVXL and RVTY stock pages for the full models.
Not investment advice.